Dynavax Technologies Corp
NASDAQ:DVAX

Watchlist Manager
Dynavax Technologies Corp Logo
Dynavax Technologies Corp
NASDAQ:DVAX
Watchlist
Price: 13.5 USD -1.17% Market Closed
Market Cap: 1.8B USD
Have any thoughts about
Dynavax Technologies Corp?
Write Note

Dynavax Technologies Corp
Total Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Dynavax Technologies Corp
Total Equity Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Total Equity Analysis
Latest Figures & CAGR of Competitors

Company Total Equity CAGR 3Y CAGR 5Y CAGR 10Y
Dynavax Technologies Corp
NASDAQ:DVAX
Total Equity
$642.8m
CAGR 3-Years
98%
CAGR 5-Years
127%
CAGR 10-Years
16%
Abbvie Inc
NYSE:ABBV
Total Equity
$6B
CAGR 3-Years
-24%
CAGR 5-Years
N/A
CAGR 10-Years
3%
Gilead Sciences Inc
NASDAQ:GILD
Total Equity
$18.4B
CAGR 3-Years
-5%
CAGR 5-Years
-2%
CAGR 10-Years
3%
Amgen Inc
NASDAQ:AMGN
Total Equity
$7.5B
CAGR 3-Years
-3%
CAGR 5-Years
-7%
CAGR 10-Years
-11%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Total Equity
$15.6B
CAGR 3-Years
18%
CAGR 5-Years
24%
CAGR 10-Years
30%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Total Equity
$29.3B
CAGR 3-Years
19%
CAGR 5-Years
23%
CAGR 10-Years
28%

See Also

What is Dynavax Technologies Corp's Total Equity?
Total Equity
642.8m USD

Based on the financial report for Jun 30, 2024, Dynavax Technologies Corp's Total Equity amounts to 642.8m USD.

What is Dynavax Technologies Corp's Total Equity growth rate?
Total Equity CAGR 10Y
16%

Over the last year, the Total Equity growth was 11%. The average annual Total Equity growth rates for Dynavax Technologies Corp have been 98% over the past three years , 127% over the past five years , and 16% over the past ten years .

Back to Top